Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

NCT ID: NCT03773965
Registry status: Recruiting
Study type: Interventional
Phase: Phase 3
Sponsor: Eli Lilly and Company
Conditions: Juvenile Idiopathic Arthritis

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)

Enrollment: 190 participants (Estimated).

What is being studied

Intervention: baricitinib
Drug: Baricitinib

Who may be eligible

Ages: 1 Year to 18 Years
Sex: All
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Participants must have completed a previous study of baricitinib for the treatment of JIA. Exclusion Criteria: * Participants must not have had a permanent discontinuation of baricitinib in the prior study. * Participants must have not developed an allergy to baricitinib.

Study locations

78 study locations are listed.

Recruiting site status is explicitly provided for 78 locations; 49 are listed as Recruiting.

Countries: Argentina, Australia, Austria, Belgium, Brazil, China, Czechia, Denmark, France, Germany, India, Israel, Italy, Japan, Mexico, Poland, Russia, Spain, Turkey (Türkiye), United Kingdom

Sample of listed locations

UZ Gent — Ghent, 9000, Belgium — Recruiting
UZ Leuven — Leuven, 3000, Belgium — Recruiting
Faculdade de Medicina da UNESP — Botucatu, 18618-686, Brazil — Recruiting
Instituto da Crianca do Hospital das Clinicas da FMUSP — São Paulo, 05403-000, Brazil — Recruiting
Universidade Federal de Sao Paulo — São Paulo, 04024-002, Brazil — Recruiting
Children's Hospital of Soochow University — Suzhou, 215000, China — Recruiting
Detska nemocnice FN Brno — Brno, 613 00, Czechia — Recruiting
Fakultni nemocnice Motol — Prague, 150 06, Czechia — Recruiting
Vseobecna fakultni nemocnice v Praze — Prague, 12808, Czechia — Recruiting
Aarhus Universitetshospital, Skejby — Aarhus, 8200, Denmark — Recruiting
Hospices Civils de Lyon - Hôpital Femme Mère Enfant — Bron, 69500, France — Recruiting
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre — Le Kremlin-Bicêtre, 94270, France — Recruiting
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau — Nîmes, 30029, France — Recruiting
Hôpital Universitaire Necker Enfants Malades — Paris, 75015, France — Recruiting
Centre Hospitalier Universitaire de Poitiers — Poitiers, 86021, France — Recruiting
Sir Ganga Ram Hospital — New Delhi, 110060, India — Recruiting
Christian Medical College Vellore — Vellore, 632004, India — Recruiting
Rambam Health Care Campus — Haifa, 3109601, Israel — Recruiting
Meir Medical Center — Kfar Saba, 4428164, Israel — Recruiting
Schneider Children's Medical Center — Petah Tikva, 49202, Israel — Recruiting
Sheba Medical Center — Ramat Gan, 5262100, Israel — Recruiting
Institute of Science Tokyo Hospital — Bunkyō, 113-8519, Japan — Recruiting
Chiba Children's Hospital — Chiba, 266-0007, Japan — Recruiting
Kagoshima University Hospital — Kagoshima, 890-8520, Japan — Recruiting
Kanazawa University Hospital — Kanazawa, 920-8641, Japan — Recruiting

Study details

Start date: April 5, 2019
Primary completion date: July 1, 2031
Completion date: July 1, 2031
First posted: December 12, 2018

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT03773965
Registry last updated: October 7, 2026
QualifiedStudies registry data refreshed: October 12, 2026
QualifiedStudies record fetched: October 12, 2026

View NCT03773965 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ